COVID-19

Thank you front liners

COVID-19 Vaccines

COVID-19 vaccinations are being distributed and administered across the U.S., and right here in the Capital Region. The vaccine is completely free to all patients

IMPORTANT: To protect our community, CDPHP is encouraging all eligible providers to register, prepare, and order vaccine. The NYS Department of Health has outlined the following steps for providers willing to administer the vaccine:

  1. Register with the New York State Immunization Information System (NYSIIS)

  2. Enroll in the COVID-19 vaccination program

  3. Order, receive, and administer the vaccine

For step by step instructions, please visit the NYS Department of Health website.

The Johnson & Johnson vaccine requires only 1 dose; Moderna and Pfizer require 2 doses 4 weeks and 3 weeks apart, respectively.

The Pfizer vaccine is licensed for age 12 and older; the other two vaccines are licensed for age 18 and older.

An Important Note about Medicare Advantage

The federal government will bear the cost of the vaccine itself, while CDPHP will pay for the administration of the vaccine. This is true for all product lines EXCEPT Medicare Advantage, in which case CMS has determined the cost of the vaccine and its administration will be covered under Medicare fee-for-services (Original Medicare). As such, claims should not be submitted to CDPHP, but should be submitted directly to Medicare FFS.

For detailed instructions on how to bill Original Medicare, head to the CMS website.

CDPHP strongly encourages all eligible members to get the COVID-19 vaccine, and continues urging all members to get a flu shot.

To receive timely notifications of any new measures we’ve adopted, please subscribe to our provider newsletter.

Approved COVID-19 Antibody Treatments

The Food and Drug Administration (FDA) recently granted emergency use authorization for antibody treatment of mild to moderate COVID-19 in adults and pediatric patients (12 and older) who are at high risk for progressing to severe COVID-19. This includes those who are 65 and older, or those with certain chronic medical conditions.

The monoclonal antibody treatments authorized for emergency use were developed by Eli Lilly (Bamlanivimab) and Regeneron (Casirivimab and Imdevimab). Detailed information on these treatments is available on the CMS website.